M itochondria are well-known for the supply of cellular energy, although these organelles are involved in a wide range of important cellular processes. Mitochondrial physiological functions include energy production, reactive oxygen species (ROS) production and detoxification, fatty acid oxidation, iron-sulfur cluster biogenesis, stress sensing, Ca 2+ signaling, cross-talk with other organelles, biogenesis, fusion/fission events, and orchestration of some cell death modalities ( Figure 1 ). 1, 2 When cellular stress reaches a certain threshold or in pathological conditions, mitochondria can adapt morphologically by fusion/fission processes and metabolically by regulating respiratory substrate utilization and ATP production ( Figure 2 ). But when mitochondrial alteration and dysfunction are excessive, their elimination by autophagy or cell death is triggered ( Figure 2 ). As a result, mitochondrial homeostasis is a complex and tightly regulated process, and failure to maintain mitochondrial homeostasis is frequently associated with severe human pathologies. 1, 2 In 1976, Hunter et al 3 discovered a phenomenon called permeability transition (PT) as a result of the opening of a channel, the permeability transition pore (PTP), which results in a modification in permeability properties of the mitochondrial inner membrane (IM). Since PT description, major efforts have been accomplished to decipher its physiological role and, more recently, its role in cell death and pathology. 2, [4] [5] [6] [7] [8] This allowed its recognition as a potent pharmacological Original received July 14, 2012; revision received September 5, 2012 ; accepted September 14, 2012 . In August 2012, the average time from submission to first decision for all original research papers submitted to Circulation Research was 11.48 days.
Current Definitions and Controversies
PT is defined as a sudden increase in the unselective permeability to solutes of molecular mass <1.5 kDa across mitochondrial membranes. PT is classically assessed by the measurement of fluorescent probes such as calcein/cobalt in situ. 14, 15 Other methods can be used in vitro (ie, isolated mitochondria suspension), such as the measurement of absorbance, which reflects the colloid-osmotic swelling of the matrix and the accessibility of matricial enzymes, such as citrate synthase after Ca 2+ -induced PT. [16] [17] [18] [19] PT is a conserved process through evolution. Since its former description, PT has been observed in mammalian and nonmammalian eukaryotes, such as plant, zebrafish, and fungi, and refers to the opening of a megachannel spanning the IM on the basis of electrophysiological measurements. 20 A preferential PTP location at the mitochondrial contact sites between IM and OM has been proposed and would correlate with physiological roles in energy transfer and apoptosis by facilitating specific protein-protein interactions and conformational changes. 21, 22 PT was first observed in isolated beef heart mitochondria. 3 Experiments revealed that mitochondria respond to Ca 2+ , phosphate, and fatty acids levels by a unique mechanism, resulting in a rapid change in IM permeability, allowing an unspecific entry of water and solutes into the mitochondrial matrix. Consequences of PT induction by Ca 2+ are immediate and consisted of mitochondrial matrix swelling, induction of ATPase activity, uncoupling of oxidative phosphorylation, and loss of respiratory control. Interestingly, magnesium and ATP inhibited PT, suggesting that PT is an intrinsic and highly controlled process. Later, PT was associated with ROS increase (eg, anion superoxide and hydrogen peroxide) and ROS-induced damage to lipids, DNA, and proteins, cristae remodeling, outer membrane (OM) rupture, and cytochrome c release, thereby implicating PT in cell death. 8, [23] [24] [25] [26] [27] PT also was proposed to provoke a depletion of mitochondrial and cytosolic nicotinamide adenine dinucleotide, and to be a causative event in the death of myocytes 28 and hepatocytes 29 in postischemic reperfusion damages. Endogenous stimuli that can modulate PT function include either direct molecular effects (eg, Ca 2+ , fatty acids, Bax, Bid, sirtuin-3, p53) or indirect pathophysiological processes (eg, hypoxia, exercise, and aging). 8, [30] [31] [32] [33] [34] [35] Thus, the existence of several, sometimes redundant, regulating signaling pathways and molecules strongly supports the physiological functions of PTP. 36 Currently, a plethora of various exogenous molecules have been identified to induce or inhibit PT in various situations (Table 1) . This applies to endogenous proteins, xenobiotics, chemotherapeutic drugs, phytomolecules, viral and microbial molecules, and toxins. Unfortunately, numerous PTP inhibitors can have off-target effects, such as the inhibition of the phosphatase calcineurin, limiting their therapeutic use. Interestingly, some PTP-targeting molecules currently are being evaluated in clinical trials such as 4-(N-(Sglutathionylacetyl) amino) phenylarsenoxide for cancer treatment of refractory tumors. 37 The molecular mechanisms of 4-(N-(S-glutathionylacetyl) amino) phenylarsenoxide antiangiogenic efficacy in vivo have long been controversial but recently have been shown to involve a binding to cystein residues of the adenine nucleotide translocase (ANT). 38 In the past, a debate focused on the notion of PTP as a dynamic multiprotein complex. Several studies supported the hypothesis that a unique composition could be elucidated by biochemical and biophysical means. This had, and still has, tremendous implications for pathophysiology and target identification in diagnostic and therapeutic perspectives. However, some researchers favored the hypothesis that although the PT phenomenon can be observed in vivo, ex vivo, in cellulo, and in isolated mitochondria, no precise composition could be determined as a result of basic reasons, including voltage conductance dependency, tissue specificity of protein expression patterns, and methodological bottlenecks. One alternative hypothesis that is supported by recent literature is that PTP identity might be multiple and dynamic (ie, evolving with the cell status or cell treatment), and might depend on the model. 65, 66 Another debate concerned the cell death modality that PTP can mediate, apoptosis compared with necrosis. Thus, in many cellular models, PTP opening dissipates the transmembrane inner potential, triggers matrix swelling, cytochrome c release into the cytosol, and subsequent cell death, and pharmacological inhibition by CsA can prevent or delay these events. An alternative view zis that in the presence of high amount of ATP, apoptosis execution can proceed, whereas in the absence of ATP (required to execute some critical events such as caspase activation) and in case of [67] [68] [69] This led to the hypothesis that PT, which induces an arrest of mitochondrial bioenergetics and then cessation of ATP synthesis and ROS production, would favor necrosis rather than apoptosis. But recent genetic evidences obtained in mice and in cellulo indicates that cell death pathways can be interconnected at multiple levels, [70] [71] [72] even during cardiac remodeling after myocardial I/R. 73 Therefore, the frontier among apoptosis, necrosis, and regulated necrosis is far from clear, which is consistent with a role of PTP in multiple modalities of cell death. Then, the key question is whether PTP opening is a rate-limiting event or a late event when contributing to injury damage. Plausibly, the answer may be highly dependent on the pathophysiological model.
PTP Is an Unselective Voltage-Dependent Channel of Unknown Identity: Biochemical and Biophysical Evidences and Their Limits
Electrophysiology is the method of choice in the characterization of PTP channel function and regulation. The seminal observation, which has been further confirmed, consisted of the analysis of mitochondrial membrane channel activity in response to Ca 2+ stimulation and revealed that PTP channel is voltage-dependent, and its largest conductance is ≈1.2 nS, with many lower substates. [74] [75] [76] This high conductance prompted the scientific community to name this pore the megachannel for several years. 75 Importantly, electrophysiologists established the occurrence of unselective channels with large and multiple conductance states in mitochondria from different cellular origins and gave invaluable insights into their regulation by Ca 2+ and thiol modification. 77 Because of the differences in permeability of both mitochondrial membranes, the PTP component forming the channel seems to be located in the IM, with this channel being regulated by interaction with the matricial protein cyclophilin D (CypD).
One promising candidate for being the IM protein was the ANT or ADP/ATP carrier based on several biochemical and cellular evidences obtained in mammals, nematode, and yeast. 47, 78, 79 Briefly, pull-down experiments suggested that CypD can interact with the voltage-dependent anion channel (VDAC) and ANT. 80, 81 In addition, Ca 2+ can convert ANT, which exchanges ADP and ATP in physiological conditions, into a channel. 82, 83 The conductance of this channel was enhanced by association with the proapoptotic Bax and closed by Bcl-2, [84] [85] [86] atractyloside, and bongkrekic acid, which are known specific pharmacological inhibitors of ANT. 50 Overall, these studies led to the proposal of a working model of a pore spanning both mitochondrial membranes and that is composed of several interacting proteins such as VDAC (OM), hexokinase (cytosol), translocator protein (OM), ANT (IM), creatine kinase (intermembrane space in brain, muscles, and heart), and CypD (matrix), called the PTP complex. 84, 87 This model was supported by yeast hybrid studies and coimmunoprecipitation and was confirmed by blue native electrophoresis, showing the existence of, at least, 5 dynamic complexes containing various combinations of VDAC, ANT, and CypD in rat liver mitochondria. 65 However, ANT is expressed as 4 isoforms in humans and as 3 isoforms in mouse, but biochemistry and cell biology did not succeed in a definitive demonstration of the role of each ANT isoform in PTP so far. It seemed that the various isoforms might have different roles depending on the pathophysiological context. 88 Thus, ANT1 and ANT3 are proapoptotic and ANT2 and ANT4 are antiapoptotic in cancer cells, [89] [90] [91] [92] [93] whereas in cardiomyocytes ANT1 overexpression did not induce apoptosis and prevented diabetic cardiomyopathy in mice. 94 Another key candidate was VDAC 95, 96 because of its own channel activity in the OM and interaction with other putative components, but experiments showing that PT may still occur in mitoplasts suggested that VDAC was dispensable in the PTP composition. 77 Furthermore, pharmacological inhibition studies pointed out a positive role of translocator protein in PTP opening and cell death, with this protein playing a role in mitochondrial homeostasis via its involvement in steroidogenesis, Ca 2+ and ROS signaling, and cell death. 97 However, some translocator protein ligands, such as TRO40303, do not prevent the classical PTP activation in isolated mitochondria, 61 questioning the mechanisms of action of this compound. An emerging hypothesis suggests that PTP pore-forming proteins could belong to the protein import machinery family, ie, the translocase of the IM (TIM) family. 77 Thus, TIM23, which behaves as a permanently open channel in reconstituted membranes, is regulated in situ by TIM50 to maintain the IM permeability barrier and the mitochondrial electrochemical proton gradient. 98 Depending on the presence of a presequence, TIM50 allows its on-demand opening for protein translocation. 98 An interesting hypothesis is that TIM23 or a homolog would form the PTP channel, which would constitute a conceptual breakthrough and open original perspective.
Genetic Studies Failed to Confirm PTP Former Candidates but Identified PTP Regulators
Until the mid 1990s, the implication of candidate proteins in PTP was challenged by pharmacological inhibition but not by gene silencing. Progressively, different PTP candidates have been knocked out in mice ( Table 2) . As previously written, suspected key IM components were ANT and its isoforms. Surprisingly, PTP opening still occurred in mitochondria from liver deficient for both Ant1 and Ant2 with higher doses of Ca 2+ . 99 PTP opening from this double knockout (KO) study suggests a regulator rather than an essential structural role for ANT, but this result was obtained before the identification of a third isoform, ANT4.
100,101 Thus, Ant KO was not complete, and even if ANT4 expression was not ubiquitous and more predominant in the testis, a compensatory role that allowed a functional pore opening cannot be excluded. To test that, a triple KO mouse is required but is not yet available.
A similar story for the OM partner concerned VDAC, because in mammals 3 isoforms have been characterized. Like Ant2, deletion of Vdac2 was lethal during development of mice embryos (Table 2 ). Vdac1/3 single or double deficiencies led to mice growth restriction. 126 Despite some mitochondrial energy defect, PTP opening was unaltered in most tissues. To exclude a role from VDAC2, Vdac1/3 double KO fibroblasts were treated with a small interfering RNA against Vdac2 and showed normal PTP opening after Ca 2+ and oxidative stress stimuli. 126 These results failed to support a role for VDAC in the PTP. 120, 121 However, small interfering RNAs never lead to a complete deficiency, and even a low level of residual VDAC2 could be sufficient to allow normal PTP opening.
As stated in the Introduction, PT implies an inhibition by CsA, another candidate was CypD; however, almost normal pore opening in CypD-deficient mitochondria and cells was observed. 112 However, the Ca 2+ load necessary for PTP opening was more important. In an independent study, experiments with mitoplasts from mice genetically invalidated for CypD revealed that Ca 2+ -induced PT could still be measured, 112, 127 demonstrating a regulator role of CypD and suggesting the existence of other proteins forming the PTP channel.
More recently, the mitochondrial phosphate carrier, PiC, has been favored to be part of the PTP. So far, only the RNA interference approach has been used, and decreased PiC expression by 65% to 80% in HeLa cells did not block mitochondrial Ca 2+ accumulation and pore opening. 118 However, stronger and rigorous genetic analysis is required to ascertain the implication of PiC in the PTP.
Creatine kinase, hexokinase, translocator protein, and Bcl-2 family members also have been proposed to regulate or to be part of the megachannel. KO mouse of these different proteins did not reveal a specific role for any of them (Table 2) . It seems that the result of the genetic deletion is not strong enough to decipher the exact identity of proteins involved in PTP. Thus, after >15 years of intense research, ANT and CypD appear as PTP regulators, and an essential role for VDAC and Bax is excluded.
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Low-and High-Conductance Modes of the Channel Determine Cellular PTP Roles
Irrespective of the PTP identity, pioneer work revealed a prominent role of PTP in Ca 2+ homeostasis. Importantly, CsA was shown to prevent the Ca 2+ -induced swelling of mitochondria, 54 . In this mode, PTP flickering did not trigger a detectable matrix swelling. A major mode of regulation of this mode has been proposed to be the matrix pH 132 ( Figure 1 ). To further study the relationship between matricial-free and bound Ca 2+ and PT, Chalmers and Nicholls 133 investigated liver-isolated and brain-isolated mitochondria in vitro. Isolated mitochondria obviously do not model in situ mitochondria, but they allow an accurate manipulation of extramitochondrial Ca 2+ concentration and intramatricial Ca 2+ measurement. 133 They found that on Ca 2+ continuous infusion, mitochondrial Ca 2+ accumulation proceeds sequentially, followed by PT activation. They concluded that intramatricial phosphate plays an important role via its capacity to form a complex with Ca 2+ and suggested that their finding might be relevant to pathological neuronal calcium overload.
Another decisive insight into PTP function was brought by in situ experiments using the loading of hepatocytes with the fluorescent probe calcein and its quencher, the cobalt anion. 14 Because cobalt cannot enter into mitochondria, calcein only fluoresces in the mitochondrion matrix and, after Ca 2+ addition to induce PT, calcein fluorescence is quenched by cobalt. Thus, PTP, which is frequently described as a closed channel in resting cells, seems to flicker between opened and closed states of low conductance and upon stimulation exhibits sudden longlasting openings, which are responsible for mitochondrial uncoupling, mitochondrial dysfunction, and cell death. 14 In skeletal muscle mitochondria, Ca
2+ also can open PTP in the presence of phosphate, leading to the rapid loss of transmembrane inner potential. This opening is controlled, at least in part, by the respiratory substrates 53 (Figures 1 and 2 ). For instance, lower Ca 2+ loads are required when electrons are provided to Tg (heart) Yes Yes Heart mitochondria overexpressing CypD showed alterations in mitochondrial architecture and loss of cristae. TUNEL staining of the heart was increased with a corresponding cardiac hypertrophy and reduction in cardiac function over time
103, 114
Hexokinase II KO (WB) E7.5 lethality (ND) HKII +/− mice displayed increased hypertrophy and fibrosis in response to pressure overload HKII and its mitochondrial binding negatively regulate cardiac hypertrophy by decreasing ROS production via mitochondrial permeability Reduction in HKII levels causes altered remodeling of the heart in I/R by increasing cell death and fibrosis and reducing angiogenesis complex I rather than to complex II or IV. This may be directly linked to the rate of electron flow through complex I. A major consequence of this observation is that the bioenergetics activity of mitochondria can directly influence the PTP opening probability and then can predict the cell susceptibility to injury. For instance, several studies established a strong correlation among an increased probability of PTP opening, mitochondrial dysfunction, and age-related myocardial alterations. 134 At a more integrated level, mitochondria are interconnected within the so-called mitochondrial network, undergo fusion and fission events to adapt to stress, 135 and communicate with other organelles such as the endoplasmic/sarcoplasmic reticulum via microdomains to transfer Ca 2+ and trigger some proapoptotic signaling cascade in case of stress. 63, [136] [137] [138] For instance, in the heart, a partial loss of optic atrophy type 1 (OPA1), an IM protein involved in mitochondrial fusion, affects the mitochondrial network morphology, PTP sensitivity to Ca 2+ , and cardiac adaptation to pressure overload. 139 But the links among mitochondrial dynamics, PTP, and pathology remain largely unknown and have to be further explored.
Metabolic Regulation of PTP
In normal cellular physiology, a tight regulation is needed to avoid the vicious cycle of PT and the subsequent mitochondrial uncoupling with its deleterious consequences. Therefore, several protective signaling pathways converge to decrease the susceptibility of long-lasting PTP openings of high conductance and stabilize the low-conductance mode and the PTP closed conformation. This is achieved by posttranslational modifications of key proteins, such as phosphorylation, acetylation, and prevention of key protein oxidation. It is now well-known that sirtuin-3, a mitochondrial deacetylase, 140 protects cardiomyocytes from hypertrophy and cell death. 141 Thus, among other sirtuin-3 targets, CypD is maintained in a nonacetylated form by sirtuin-3, with its acetylation leading to an increase in PTP sensitivity and cell death. 33, 142 In addition, the implication of several kinases in cardioprotective signaling pathways converging to the mitochondrion has been well-documented. For instance, protein kinase A and glycogen synthase kinase 3β phosphorylate VDAC, with opposite consequences on the flux of adenine nucleotides within the mitochondrial matrix and interaction with the cytoskeleton protein, tubulin. 143, 144 In addition, VDAC-hexokinase II may favor PTP closure because disruption of this interaction and a reduced level of hexokinase II clearly sensitize mitochondria to depolarization and cell death in cardiac I/R. 117, [145] [146] [147] In contrast, a lack of glycogen synthase kinase 3-dependent VDAC increases PTP sensitivity to Ca 2+ -induced opening during lipid accumulation in hepatocytes, favoring a cytochrome c release into the cytosol, 148 suggesting some tissue-specific PTP regulation. Aerobic metabolism is intimately associated with ROS production, which can be harmful when produced in excess or in a prolonged manner. Direct protein oxidation or protein modification by lipid aldehydes (eg, carbonylation) is linked to pathological alterations of metabolism and induction of apoptosis and is balanced by antioxidant detoxification under normal conditions. 149, 150 Thus, ANT is particularly sensitive to oxidative modification (eg, nitric oxide [NO], carbon monoxide [CO], 4-hydroxy-trans-2-nonenal [HNE]), with a direct (positive or negative) impact on PTP opening susceptibility. 151 In line with this, Cys-203 in CypD seems to be crucial for redox modulation of PTP activation by S-nitrosylation, which proved to be important in I/R. 152 More generally, mitochondrial damages and misfolded proteins can be triggered by Ca 2+ overloading, ROS and nitrogen species, decreased mitochondrial transmembrane inner potential, and oxidation of pyridine nucleotides and glutathione. 153 When misfolded proteins became excessive, Lemasters et al demonstrated that mitochondria are targeted for autophagic degradation and recycling and proposed that misfolded proteins might form a PTP ( Figure  1) . 154 More recently, nonproteinaceous molecules (such as inorganic polyphosphate) have been proposed as a potent activator of PTP in cardiac myocytes. 155 
Animal Models Support a Role of PTP and Its Regulators in Cardiac Physiology and Pathophysiology
Important roles of PTP and PTP regulators in heart function and reproduction 156 have been discovered with KO mice models ( Table  2 ) and trained animals (treadmill, 10 weeks). 35 Thus, comparison , oxidative stress-induced PTP, and cell death were unaltered in fibroblasts lacking VDAC1, VDAC2, VDAC3, VDAC1/3, or VDAC1/2/3 (using siRNA for VDAC2) Although the PTP may be perturbed by the absence of VDACs in the brain, additional studies of PTP function in other tissues and cell types lacking each VDAC isoform failed to support an essential role for VDACs in the PTP 120, 126
ANT indicates adenine nucleotide translocase; CK, creatine kinase; CypD, cyclophilin D; DKO, double knockout; HK, hexokinase; I/R, ischemia/reperfusion; NA, not available; ND, not determined; PBR, peripheral benzodiazepine receptor; PiC, phosphate carrier; PTP, permeability transition pore; Tg, transgenic; TSPO, translocator protein; VDAC, voltage-dependent anion channel; WB, whole body. 
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of wild-type, genetic, and transgenic mice supported a role of PTP in life and death pathways, along with the importance of PTP in cardiac physiology. KO mice for Ant, Vdac, and HkII displayed increased sensitivity to cardiac injuries; however, CypD KO mice were protected. Although Ant2 KO is embryonic-lethal because of abnormal cardiac development and a role in cell death, 105 complete loss of function of the heart and muscle-specific ANT1 is associated with mitochondrial myopathy and cardiomyopathy. 102 Conversely, myocardial overexpression of ANT1 ameliorates diabetic cardiomyopathy in mice and improves hypertension-induced heart disease in rats.
94 Vdac2 cardiac-specific KO leads to early mortality because of progressive fibrosis and cardiomyopathy. 123 Hypertrophy and fibrosis in response to pressure overload or I/R were increased in heterozygous HkII-deficient mice. 116 On the contrary, CypD −/− mice are protected from I/R injury, whereas mice overexpressing CypD in the heart show mitochondrial swelling and spontaneous cell death. 114 These results are consistent with cardiac protection conferred by CsA.
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Conclusions
Past and recent research definitely established the proof of concept of PTP playing important roles in mitochondrial homeostasis and in many aspects of cell physiology, notably for heart function. Interestingly, important advances concerned the understanding of the cellular regulation of PTP and the distinction between the conductance states. The low-conductance state of PTP has a prominent role in mitochondrial calcium release and transmission under the control of metabolism and matrix pH, whereas the highconductance state leads to cell death induction. However, whether genetic studies helped to clarify the role of PTP regulators and to identify the protein forming the PTP channel is still an ongoing conundrum. Because target identification and validation are prerequisites for the design of targeted therapy based on PTP inhibition, the determination of PTP identity still remains a priority.
